THX Pharma
THX Pharma (ALTHX) is a Biotechnology company in the Healthcare sector, listed on Euronext Paris. This page provides the complete earnings calendar, dividend schedule, and financial data for THX Pharma in 2026.
Earnings calendar
Next earnings date
—
Not scheduled
EPS estimate
—
Revenue estimate
—
Past earnings
No earnings history available.
Dividend calendar
No dividend history available.
Company profile
Theranexus, a biopharmaceutical enterprise, specializes in the creation of potential medications for ailments affecting the central nervous system. Their primary investigational compound, THN102, is presently undergoing Phase II clinical evaluation for conditions related to sleep and wake cycles. Furthermore, they are developing THN201 to target neurocognitive challenges associated with Alzheimer's disease, and THN101 for the management of neuropathic discomfort. This company commenced operations in 2013 and is situated in Lyon, France.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- France
- Exchange
- Euronext Paris
- CEO
- Mathieu Charvériat
- Employees
- 12
- IPO date
- 30 Oct 2017
- ISIN
- FR0013286259
- Website
- thxpharma.com
Frequently asked questions
Where is THX Pharma stock listed?
THX Pharma (ALTHX) is listed on Euronext Paris.